The LAM1-specific pathways included IL-1 and IL-6 signaling, whereas LAM2-specific populations consisted of neuronal-, inflammatory-, cardiac-hypertrophy-, and growth-factor-related pathways (Data S1). The gene discussed is SELL; the disease is cardiac hypertrophy.